Polymorphism of the stress protein HSP70-2 gene is associated with the susceptibility to the nasopharyngeal carcinoma

被引:60
作者
Jalbout, M
Bouaouina, N
Gargouri, J
Corbex, M
Ben Ahmed, S
Chouchane, L [1 ]
机构
[1] Fac Med Monastir, Lab Immunooncol Mol, Monastir 5019, Tunisia
[2] CHU Farhat Hached, Serv Cancerol Radiotherapie, Sousse, Tunisia
[3] Ctr Natl Transfus Sanguine, Sfax, Tunisia
[4] CIRC, Unite Epidemiol Genet Canc, Lyon, France
[5] CHU Farhat Hached, Serv Carcinol Med, Sousse, Tunisia
关键词
tumor necrosis factor; stress protein; nasopharyngeal carcinoma;
D O I
10.1016/S0304-3835(02)00697-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Several studies have shown statistical evidence of association between nasopharyngeal carcinoma (NPC) and specific human leukocyte antigen (HLA) alleles and highlighted the presence of candidate genes for this cancer within or nearby the HLA. Given their chromosomal location within HLA and their determining role in the immune response to tumor cells, we designed a case-controlled study to investigate the potential association of the genetic variation of the tumor necrosis factor-alpha (TNFalpha) and that of the heat shock protein 70-2 (HSP70-2) with NPC. We used the polymerase chain reaction and restriction enzyme digestion to characterize the variation of the TNF-alpha promoter region and that of the HSP70-2 gene in 140 Tunisian patients with primary NPC and 274 healthy control subjects. No association was found between genetic variations in TNF-alpha and the risk of NPC in Tunisians. In contrast, a significant relative risk of NPC was found associated with the HSP70-2 homozygous genotype (P2/P2) (OR = 2.309; P = 0.006). The P2/P2 genotype of the HSP70-2 gene may be a marker of increased risk of NPC in Tunisians. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:75 / 81
页数:7
相关论文
共 44 条
[1]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[2]   The tumor necrosis factor ligand and receptor families [J].
Bazzoni, F ;
Beutler, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (26) :1717-1725
[3]  
Burt RD, 1996, CANCER EPIDEM BIOMAR, V5, P879
[4]   POLYMORPHISM IN TUMOR-NECROSIS-FACTOR GENES ASSOCIATED WITH MUCOCUTANEOUS LEISHMANIASIS [J].
CABRERA, M ;
SHAW, MA ;
SHARPLES, C ;
WILLIAMS, H ;
CASTES, M ;
CONVIT, J ;
BLACKWELL, JM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05) :1259-1264
[5]  
Daniilidis M, 1997, ONCOLOGY-BASEL, V54, P185
[6]  
Dardari R, 2001, INT J CANCER, V92, P294, DOI 10.1002/1097-0215(200102)9999:9999&lt
[7]  
::AID-IJC1177&gt
[8]  
3.0.CO
[9]  
2-9
[10]  
FUJIKI H, 1994, CANCER DETECT PREV, V18, P1